Published on 23rd January 2012
Angle's 90%-owned portfolio company, Parsortix, which specialises in medical diagnostics, has used its cell separation device to successfully capture circulating tumour cells (CTCs) in cancer patient blood.
URL: http://www.digitallook.com/dl/news/story/19827358/...